Park Medi World working capital

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	FY26Mar 2026

	3.58×
	128.99×
	134.45×
	−1.88×
	3.00×
	0.60×
	1.20×
	0.74×

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

PARKHOSPS₹221.25

Park Medi World Ltd.

· Pharma & Health

₹ CrorePeersMAXHEALTH FORTIS MEDANTA METROPOLIS MARKSANS RUBICON JLHL SHILPAMEDMcap ₹9,556 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

	Ratios — % unless marked × 12 Months Ending	FY26 31/03/2026
	Inventory Days (DIO)	3.58
	Receivable Days (DSO)	128.99
	Payable Days (DPO)	134.45
	Cash Conversion Cycle (days)	-1.88
	Working Capital Turnover	3.00
	Asset Turnover	0.60
	Cash Conversion (CFO/Net Income)	1.20
	CFO/EBITDA	0.74

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.